FDA Import Refusal 112-2823997-6/1/2 — Laboratoire Glaxo Smith Kline
The FDA refused shipment 112-2823997-6/1/2 from Laboratoire Glaxo Smith Kline (France) on Apr 14, 2004. The refused product falls under Drugs and Biologics — LAMIVUDINE (ANTI-VIRAL). Cited charge: 75 This firm has 4 other import refusals on record.
Refusal details
- Date
- Apr 14, 2004
- Country
- France
- Product Category
- Drugs and Biologics
- Product Code
- 62VCA32 LAMIVUDINE (ANTI-VIRAL)
- Charges
- 75